Skip to main content

INGR Q4 Deep Dive: Clean Label and Solutions Growth Offset by Operational Challenges

INGR Cover Image

Food ingredient solutions provider Ingredion (NYSE: INGR) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 2.4% year on year to $1.76 billion. Its non-GAAP profit of $2.53 per share was 3.1% below analysts’ consensus estimates.

Is now the time to buy INGR? Find out in our full research report (it’s free for active Edge members).

Ingredion (INGR) Q4 CY2025 Highlights:

  • Revenue: $1.76 billion vs analyst estimates of $1.79 billion (2.4% year-on-year decline, 1.6% miss)
  • Adjusted EPS: $2.53 vs analyst expectations of $2.61 (3.1% miss)
  • Adjusted EBITDA: $285 million vs analyst estimates of $304 million (16.2% margin, 6.2% miss)
  • Adjusted EPS guidance for the upcoming financial year 2026 is $11.40 at the midpoint, missing analyst estimates by 1%
  • Operating Margin: 12.5%, up from 9% in the same quarter last year
  • Constant Currency Revenue fell 4.4% year on year (-0.8% in the same quarter last year)
  • Market Capitalization: $7.59 billion

StockStory’s Take

Ingredion’s fourth quarter results drew a positive market response, despite revenue and non-GAAP profit falling short of Wall Street expectations. Management attributed the operational challenges largely to production issues at the Argo facility, which led to reduced inventory and lower sales in the Food and Industrial Ingredients U.S./Canada segment. CEO James Zallie highlighted ongoing strength in the Texture and Healthful Solutions segment, especially clean label and solutions-driven sales. Zallie explained, “Texture and Healthful Solutions posted its seventh straight quarter of volume growth, up 4%,” emphasizing the segment’s momentum even as broader industry sweetener demand remained soft.

Looking ahead, Ingredion’s guidance reflects an expectation of gradual recovery in its U.S./Canada operations and continued strength in higher-margin segments. Management believes that the ongoing recovery at the Argo plant and rising demand for clean label and protein fortification will be key drivers. CFO Jim Gray flagged persistent manufacturing cost inflation and mixed demand trends as headwinds, stating, “We anticipate continued challenges through the first quarter, in line with the previous quarter.” Management also referenced targeted investments in capacity and productivity, with Zallie noting that “the actions we are taking should lead to steadily improving performance throughout 2026.”

Key Insights from Management’s Remarks

Ingredion’s Q4 performance was shaped by a mix of operational setbacks and segment outperformance, with particular strength in clean label solutions and protein fortification amid ongoing cost and volume pressures.

  • Argo facility headwinds: The Food and Industrial Ingredients U.S./Canada segment experienced a 7% decrease in net sales volume, driven by operational challenges at the Argo plant. These issues led to intermittent shutdowns, elevated maintenance costs, and lower inventory available for sale, impacting margins and segment profitability.
  • Texture and Healthful Solutions momentum: Management highlighted the Texture and Healthful Solutions segment’s seventh consecutive quarter of volume growth, with clean label ingredients and solutions leading the way, especially in Asia Pacific and U.S./Canada. Higher-margin solution sales outpaced segment growth and are expected to be accretive over time.
  • Protein fortification growth: Ingredion’s protein fortification business achieved record net sales growth exceeding 40% for the year, reflecting strong consumer demand and successful product innovation. Operating income loss in this area improved by more than $20 million.
  • LatAm segment resilience: Despite regional economic volatility, the Food and Industrial Ingredients LatAm segment delivered record operating income and margins—helped by strategic shifts toward higher-margin food and confectionery ingredients and network optimization initiatives in Brazil and Mexico.
  • Cost savings and productivity focus: The company exceeded its Cost2Compete savings target, delivering $59 million in run-rate savings. Management is now transitioning to broader enterprise productivity initiatives to further enhance efficiency and cost competitiveness across the network.

Drivers of Future Performance

Ingredion’s outlook centers on recovering U.S./Canada operations, continued demand for clean label and protein solutions, and managing cost inflation across key segments.

  • Argo facility recovery: Management expects operational improvements at the Argo plant to drive a gradual recovery in the U.S./Canada segment, with some cost impacts persisting in early 2026 but improvement anticipated in the second half. CFO Jim Gray noted that a flat year-over-year outlook reflects manufacturing inflation and lingering operational costs.
  • Clean label and solutions growth: Continued momentum in Texture and Healthful Solutions, particularly clean label and higher-margin customized ingredient solutions, is expected to support sales and margin stability. Management anticipates these offerings will deliver higher average selling prices and improved mix benefits as solution sales expand.
  • Cost pressures and productivity: Ongoing manufacturing inflation—primarily in labor and energy—remains a headwind, with management emphasizing cost control and productivity initiatives. The company will prioritize capital investments in capacity, cost savings projects, and productivity enhancements, aiming to offset inflationary pressures and maintain margin discipline.

Catalysts in Upcoming Quarters

Looking forward, the StockStory team will be watching (1) the pace of operational recovery and inventory normalization at the Argo facility, (2) the continued adoption and margin impact of clean label and protein fortification products, and (3) the ability of LatAm and Asia Pacific segments to sustain higher-margin growth despite external headwinds. Execution on enterprise productivity initiatives and effective capital allocation will also be important markers of progress.

Ingredion currently trades at $118.40, in line with $117.31 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.00
-5.62 (-2.36%)
AAPL  274.49
+5.01 (1.86%)
AMD  200.28
-41.83 (-17.28%)
BAC  55.69
+1.24 (2.28%)
GOOG  331.64
-9.06 (-2.66%)
META  669.22
-22.48 (-3.25%)
MSFT  412.68
+1.47 (0.36%)
NVDA  172.77
-7.57 (-4.20%)
ORCL  144.75
-9.92 (-6.41%)
TSLA  401.46
-20.50 (-4.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.